Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)
Ratios

Ocugen (OCGN) R&D In Process (2020)

Ocugen's R&D In Process history spans 1 years, with the latest figure at $7.0 million for Q3 2020.

  • For Q3 2020, R&D In Process changed N/A year-over-year to $7.0 million; the TTM value through Dec 2021 reached $7.0 million, changed 0.0%, while the annual FY2020 figure was $7.0 million, N/A changed from the prior year.
  • R&D In Process reached $7.0 million in Q3 2020 per OCGN's latest filing.
  • In the past five years, R&D In Process ranged from a high of $7.0 million in Q3 2020 to a low of $7.0 million in Q3 2020.